Commentary on Wittes et al: Aspirin for primary prevention of CV events - Rationally robust? Statistically significant? Clinically convincing?
作者信息
Cleland John Gf, Anzar Danyaal
机构信息
British Heart Foundation Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
University of Glasgow, Glasgow, UK.
出版信息
Clin Trials. 2025 Aug;22(4):462-465. doi: 10.1177/17407745251324865. Epub 2025 Apr 1.
Abstract
摘要
相似文献
1
Commentary on Wittes et al: Aspirin for primary prevention of CV events - Rationally robust? Statistically significant? Clinically convincing?关于维茨等人的评论：阿司匹林用于心血管事件的一级预防——合理可靠？具有统计学意义？临床说服力强？
Clin Trials. 2025 Aug;22(4):462-465. doi: 10.1177/17407745251324865. Epub 2025 Apr 1.
2
Usefulness of PA32540 in Protecting the Gastric Layer While Providing Secondary Prevention for Coronary Artery Disease.PA32540在保护胃黏膜同时为冠状动脉疾病提供二级预防中的效用。
Am J Cardiol. 2017 Oct 1;120(7):1118-1121. doi: 10.1016/j.amjcard.2017.06.052. Epub 2017 Jul 14.
3
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.氯吡格雷与缓释双嘧达莫在闭塞性血管事件二级预防中的临床疗效与成本效益：一项系统评价与经济学评估
Health Technol Assess. 2004 Oct;8(38):iii-iv, 1-196. doi: 10.3310/hta8380.
4
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.用于预防外周动脉搭桥术后血栓形成的抗血小板药物。
Cochrane Database Syst Rev. 2015 Feb 19;2015(2):CD000535. doi: 10.1002/14651858.CD000535.pub3.
5
Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.抗血栓治疗预防神经影像学检查发现的小血管疾病但无痴呆的患者认知能力下降。
Cochrane Database Syst Rev. 2022 Jul 14;7(7):CD012269. doi: 10.1002/14651858.CD012269.pub2.
6
Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.阿司匹林用于心血管疾病和癌症一级预防的预防性使用：系统评价和综述概述。
Health Technol Assess. 2013 Sep;17(43):1-253. doi: 10.3310/hta17430.
7
Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-Analysis.哪种阿司匹林剂量和制剂最适合长期预防心血管疾病和癌症？一项系统评价和网状Meta分析的证据
Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):495-504. doi: 10.1016/j.pcad.2016.02.001. Epub 2016 Feb 4.
8
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.氯吡格雷和双嘧达莫缓释制剂预防闭塞性血管事件（技术评估 90 号回顾）：系统评价和经济分析。
Health Technol Assess. 2011 Sep;15(31):1-178. doi: 10.3310/hta15310.
9
Development and Implementation of a Pharmacist-Led Aspirin Deprescribing Algorithm in Older Adults.老年人中由药剂师主导的阿司匹林减量算法的开发与实施
J Am Geriatr Soc. 2025 Jul;73(7):2081-2087. doi: 10.1111/jgs.19474. Epub 2025 Apr 15.
10
Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.阿司匹林对糖尿病患者主要不良心血管事件发生率的影响：系统评价和荟萃分析。
Cardiovasc Diabetol. 2011 Apr 1;10:25. doi: 10.1186/1475-2840-10-25.
引用本文的文献
1
From the ASPREE investigators: Response to Wittes et al.来自ASPREE研究人员：对维茨等人的回应
Clin Trials. 2025 Aug;22(4):468-470. doi: 10.1177/17407745251344560. Epub 2025 Jul 6.
本文引用的文献
1
Aspirin in primary prevention: Undue reliance on an uninformative trial led to misinformed clinical guidelines.阿司匹林用于一级预防：对一项无参考价值的试验过度依赖导致了错误的临床指南。
Clin Trials. 2025 Aug;22(4):458-461. doi: 10.1177/17407745251324866. Epub 2025 Apr 1.
2
Aspirin for Secondary Prevention of Atherosclerosis-Evidence or Dogma?阿司匹林用于动脉粥样硬化二级预防——证据还是教条？
JAMA Cardiol. 2025 Feb 1;10(2):114-116. doi: 10.1001/jamacardio.2024.4335.
3
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.阿司匹林与安慰剂作为乳腺癌辅助治疗的比较：ALLIANCE A011502 随机试验。
JAMA. 2024 May 28;331(20):1714-1721. doi: 10.1001/jama.2024.4840.
4
Aspirin for Primary and Secondary Prevention of Cardiovascular Disease: Time to Stop?阿司匹林用于心血管疾病的一级和二级预防：是时候停用了吗？
Thromb Haemost. 2022 Mar;122(3):311-314. doi: 10.1055/s-0041-1740639. Epub 2022 Jan 20.
5
Effect of Aspirin on Cancer Incidence and Mortality in Older Adults.阿司匹林对老年人癌症发病和死亡的影响。
J Natl Cancer Inst. 2021 Mar 1;113(3):258-265. doi: 10.1093/jnci/djaa114.
6
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.阿司匹林用于遗传性结直肠癌（林奇综合征）的癌症预防：CAPP2 研究的 10 年随访和基于登记的 20 年数据：一项双盲、随机、安慰剂对照试验。
Lancet. 2020 Jun 13;395(10240):1855-1863. doi: 10.1016/S0140-6736(20)30366-4.
7
The rise and fall of aspirin in the primary prevention of cardiovascular disease.阿司匹林在心脑血管疾病一级预防中的兴衰。
Lancet. 2019 May 25;393(10186):2155-2167. doi: 10.1016/S0140-6736(19)30541-0.
8
Effect of Aspirin on Disability-free Survival in the Healthy Elderly.阿司匹林对健康老年人无残疾生存的影响。
N Engl J Med. 2018 Oct 18;379(16):1499-1508. doi: 10.1056/NEJMoa1800722. Epub 2018 Sep 16.
9
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.阿司匹林对健康老年人全因死亡率的影响。
N Engl J Med. 2018 Oct 18;379(16):1519-1528. doi: 10.1056/NEJMoa1803955. Epub 2018 Sep 16.
10
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.阿司匹林用于糖尿病患者一级预防的效果。
N Engl J Med. 2018 Oct 18;379(16):1529-1539. doi: 10.1056/NEJMoa1804988. Epub 2018 Aug 26.
Zotero 插件